» Articles » PMID: 21543646

The CD3 Zeta Subunit Contains a Phosphoinositide-binding Motif That is Required for the Stable Accumulation of TCR-CD3 Complex at the Immunological Synapse

Overview
Journal J Immunol
Date 2011 May 6
PMID 21543646
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

T cell activation involves a cascade of TCR-mediated signals that are regulated by three distinct intracellular signaling motifs located within the cytoplasmic tails of the CD3 chains. Whereas all the CD3 subunits possess at least one ITAM, the CD3 ε subunit also contains a proline-rich sequence and a basic-rich stretch (BRS). The CD3 ε BRS complexes selected phosphoinositides, interactions that are required for normal cell surface expression of the TCR. The cytoplasmic domain of CD3 ζ also contains several clusters of arginine and lysine residues. In this study, we report that these basic amino acids enable CD3 ζ to complex the phosphoinositides PtdIns(3)P, PtdIns(4)P, PtdIns(5)P, PtdIns(3,5)P(2), and PtdIns(3,4,5)P(3) with high affinity. Early TCR signaling pathways were unaffected by the targeted loss of the phosphoinositide-binding functions of CD3 ζ. Instead, the elimination of the phosphoinositide-binding function of CD3 ζ significantly impaired the ability of this invariant chain to accumulate stably at the immunological synapse during T cell-APC interactions. Without its phosphoinositide-binding functions, CD3 ζ was concentrated in intracellular structures after T cell activation. Such findings demonstrate a novel functional role for CD3 ζ BRS-phosphoinositide interactions in supporting T cell activation.

Citing Articles

Charged substrate treatment enhances T cell mediated cancer immunotherapy.

Song J, Lu Y, Liu L, Han X, Meng Y, Heng B Nat Commun. 2025; 16(1):1585.

PMID: 39939595 PMC: 11821856. DOI: 10.1038/s41467-025-56858-y.


Charge-based immunoreceptor signalling in health and disease.

Shi X, He X, Xu C Nat Rev Immunol. 2024; .

PMID: 39528837 DOI: 10.1038/s41577-024-01105-6.


Focusing on CD8 T-cell phenotypes: improving solid tumor therapy.

Yao Z, Zeng Y, Liu C, Jin H, Wang H, Zhang Y J Exp Clin Cancer Res. 2024; 43(1):266.

PMID: 39342365 PMC: 11437975. DOI: 10.1186/s13046-024-03195-5.


Human T-cell receptor triggering requires inactivation of Lim kinase-1 by Slingshot-1 phosphatase.

Gomez-Moron A, Alegre-Gomez S, Ramirez-Munoz R, Hernaiz-Esteban A, Carrasco-Padilla C, Scagnetti C Commun Biol. 2024; 7(1):918.

PMID: 39080357 PMC: 11289303. DOI: 10.1038/s42003-024-06605-8.


T-cell virtuosity in ''knowing thyself".

Acuto O Front Immunol. 2024; 15:1343575.

PMID: 38415261 PMC: 10896960. DOI: 10.3389/fimmu.2024.1343575.


References
1.
Kuhns M, Davis M . The safety on the TCR trigger. Cell. 2008; 135(4):594-6. PMC: 2905657. DOI: 10.1016/j.cell.2008.10.033. View

2.
Ardouin L, Boyer C, Gillet A, Trucy J, Bernard A, Nunes J . Crippling of CD3-zeta ITAMs does not impair T cell receptor signaling. Immunity. 1999; 10(4):409-20. DOI: 10.1016/s1074-7613(00)80041-2. View

3.
Jordan M, Singer A, Koretzky G . Adaptors as central mediators of signal transduction in immune cells. Nat Immunol. 2003; 4(2):110-6. DOI: 10.1038/ni0203-110. View

4.
Srivastava R, Sinha R, Subrahmanyam G . Type II phosphatidylinositol 4-kinase beta associates with TCR-CD3 zeta chain in Jurkat cells. Mol Immunol. 2005; 43(5):454-63. DOI: 10.1016/j.molimm.2005.03.009. View

5.
Iwashima M, Irving B, van Oers N, Chan A, Weiss A . Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science. 1994; 263(5150):1136-9. DOI: 10.1126/science.7509083. View